USPTO serial 79351939
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gabrielle S. Roth
Gabrielle S. Roth Sughrue Mion, PLLC2000 Pennsylvania Ave., NW, Suite 9000Washington, DC 20006UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research services for reagents for medical use in the field of neurology; research services for reagents for medical use; medical research and medical analysis for medical research in the field of neurology, and consulting relating thereto; analysis for medical research and medical research services and consulting about the aforesaid; scientific testing, analysis and research for medical purposes in the field of neurology; scientific testing, analysing and research for medical purposes in the field of neurology; scientific and medical research and development in the field of neurology; scientific and medical research and development in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals; testing, inspection and research of cosmetics and foodstuffs; research and development in the field of diagnostic preparations relating to neurology; research and development in the field of diagnostic preparations; providing information relating to medical research in the field of medicine, chemistry and diagnostics relating to neurology; providing information relating to medical research in the field of medicine, chemistry and diagnostics; working on and evaluation of chemical analyses in the field of neurology; working on and evaluation of chemical analyses; consultancy in the field of chemistry relating to neurology; consultancy in the field of chemistry; testing, inspection and research of chemicals and pharmaceuticals relating to chemistry in the field of neurology; testing, inspection and research of diagnostic agents relating to chemistry; testing, inspection, research, evaluation and analysis of chemical ingredients in the field of neurology; testing, inspection, research, evaluation and analysis of chemical ingredients; product research and development services; product development consultancy; providing quality assurance services in the field of neurology; quality assurance consultancy services in the field of neurology; product quality testing; material testing and analysis for product quality; testing the functionality of, and research on, machines, apparatus and instruments; testing the functionality of, and research relating to, medical apparatus and instruments in the field of neurology, and their parts; testing the functionality of, and research relating to, medical apparatus and instruments and their parts; design of medical apparatus and instruments in the field of neurology; design of medical apparatus and instruments; design and development of diagnostic apparatus; design and development of medical diagnostic apparatus in the field of neurology; design and development of medical diagnostic apparatus; rental of laboratory apparatus for chemical substances in the field of neurology; rental of laboratory apparatus for chemical substances; rental of measuring apparatus; rental of measuring and laboratory machines and instruments; rental of laboratory apparatus and instruments; rental of computers; providing computer programs on data networks, namely, providing temporary use of online non-downloadable software for database management in the field of neurology; computer software design, computer programming, and maintenance of computer software; scientific and medical research and development in the field of neurology by collaborating with third parties; scientific and medical research and development by collaborating with third parties; scientific research, testing and analysis services by engineers and scientists, and their technological consultancy services in the field of neurology; pharmaceutical product evaluation by engineers and scientists, and its technological consultancy services; evaluation of chemical analyses by engineers and scientists, and its technological consultancy services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 4, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 9, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 9, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 7, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 2, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 22, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 2, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 2, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 2, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 18, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 18, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 18, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 18, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 6, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 6, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 6, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |